No Data
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $18 to $21
A Quick Look at Today's Ratings for NeoGenomics(NEO.US), With a Forecast Between $18 to $20
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), NeoGenomics (NEO) and Ultragenyx Pharmaceutical (RARE)
NeoGenomics: Balancing Growth in NGS With ADx Challenges Amid Strategic Progress
NeoGenomics | 10-Q: Q3 2024 Earnings Report
No Data
No Data